Article Information
- Received April 14, 2003
- Revision received July 7, 2003
- Accepted July 25, 2003
- First published September 17, 2003.
- Version of record published September 17, 2003.
Author Information
- Gabriele Ugolini1,
- Cédric Raoul1,
- Anna Ferri2,
- Christine Haenggeli2,
- Yoichi Yamamoto1,
- Danièle Salaün1,
- Christopher E. Henderson1,
- Ann C. Kato2,
- Brigitte Pettmann1,*, and
- Anne-Odile Hueber3,*
- 1Unitè Mixte de Recherche 382, Developmental Biology Institute of Marseille, Centre National de la Recherche Scientifique, Institut National de la Santèet de la Recherche Mèdicale, Universitè de la Mèditerranèe, Assistance Publique Marseille, Campus de Luminy-Case 907, France, 2Department of Pathology, Faculty of Medicine, Centre Mèdical Universitaire, University of Geneva, 1211 Geneva, Switzerland, and 3Institute of Signaling, Developmental Biology and Cancer Research, Centre National de la Recherche Scientifique Unitè Mixte de Recherche 6543, Centre A. Lacassagne, 06189 Nice, France
Author contributions
Disclosures
- Received April 14, 2003.
- Revision received July 7, 2003.
- Accepted July 25, 2003.
This work was supported by Institut National de la Santè et de la Recherche Mèdicale, Centre National de la Recherche Scientifique, Association Française contre les Myopathies, European Commission Contract QLG3-CT-1999-00602, Amyotrophic Lateral Sclerosis Association, and GIP-Aventis. G.U. was supported by a Marie Curie European Economic Community fellowship. We are very grateful to Odile DeLapeyrière, Jean Livet, and Vilma Arce [Unitè Mixte de Recherche (UMR) 382] for help in developing facial motoneuron cultures. We are especially grateful to Gerard Evan for support and input at the initial phase of this work. We thank the animal units at Imperial Cancer Research Fund, Ian Rosewell for assistance with transgene microinjection, and Magali Chautan-Michaud (Trophos) for help in crossing and genotyping FADD-dominant-negative mice. We thank all members of UMR 382 for helpful comments on this manuscript and throughout this work.
Correspondence should be addressed to Dr. Brigitte Pettmann, Unitè Mixte de Recherche 382-IBDM, Campus de Luminy, Case 907, 13288 Marseille Cedex 09, France. E-mail: pettmann{at}ibdm.univ-mrs.fr.
G. Ugolini's present address: Lay Line Genomics Spa, c/o Parco Scientifico Biomedico San Raffaele, Via di Castel Romano 100, 00128 Roma, Italy.
C. Raoul's present address: Neurosciences Institute, Swiss Federal Institute of Technology, LENAAB-132, CH-1015 Lausanne, Switzerland.
Y. Yamamoto's present address: Department of Neurology D-4, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Copyright © 2003 Society for Neuroscience 0270-6474/03/238526-06$15.00/0
↵* B.P. and A.-O.H. contributed equally to this work.
